About Strata Oncology
Strata Oncology is a private company based in Ann Arbor, Michigan. It has reported $29,198,842 raised in four offerings on Form D since March 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 8, 2024 | Nov 22, 2024 | $6,145,297of $10.0M target | 14 | $438K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Oct 26, 2020 | Nov 4, 2020 | $5,000,000of $10.0M target | 9 | $555K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 30, 2018 | May 11, 2018 | $11,750,001of $25.0M target | 7 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Feb 24, 2016 | Mar 4, 2016 | $6,303,544of $12.3M target | 6 | $1.0M | Equity, OptionsRule 506(b) | Form D ↗ |
| Total, four offerings | $29,198,842 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Strata Oncology's Form D filed Nov 22, 2024.
MM
Matthew Martin
Chief Financial Officer
DR
Daniel Rhodes
Executive officer and director
KF
Keith Flaherty
Director
JW
Jeffrey Williams
Executive officer and director
DR
David Rubin
Director
JP
James Pavlik
Director
JG
Jan Garfinkle
Director
Earlier filings also listed William Burkoth (director, last listed Nov 2020), Prem Tumkosit (director, last listed Nov 2020) and Nicole Walker (director, last listed Nov 2020).